1 year return (CAGR)
-6.67%
Medipharm Labs Corp Exchange (TO, CAD)
LABS.TO
0.07
0.00 (0.00%)
HealthcareDrug Manufacturers - Specialty & Generic
Loading...
3 year return (CAGR)
-4.35%
5 year return (CAGR)
-24.48%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
29.90M
Price/Sales
0.72
Ent value
30.61M
Price/Book
0.84
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-45.99%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.07 |
| Daily high | 0.07 |
| Daily low | 0.07 |
| Daily Volume | 307K |
| All-time high | 7.17 |
| 1y analyst estimate | 0.10 |
| Beta | 0.85 |
| EPS (TTM) | -0.01 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 30 Mar 2026 |
Downside potential
Loading...
Downside potential data
| LABS.TO | S&P500 | |
| Current price drop from All-time high | -99.02% | -0.24% |
| Highest price drop | -99.23% | -56.47% |
| Date of highest drop | 25 Jul 2023 | 9 Mar 2009 |
| Avg drop from high | -83.89% | -10.67% |
| Avg time to new high | 63 days | 12 days |
| Max time to new high | 1794 days | 1805 days |
News
MediPharm Labs Corp (MEDIF) reports record adjusted EBITDA and positive net income, driven by a 26% surge in international medical cannabis revenue.
August 13, 2026
TORONTO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision...
August 10, 2026
Results presented by the LiBBY study team at the Alzheimer’s Association International Conference (“AAIC”) demonstrated statistically significant improvements in agitation symptoms compared with place...
July 14, 2026
TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmaceutical company specialized in precisio...
June 17, 2026
Annual and Special Meeting to be held virtually on Wednesday, June 17, 2026 at 11:00 a.m. (Eastern Time).The Board of Directors recommends shareholders vote FOR all director nominees and resolutions, ...
May 28, 2026
MediPharm Labs Corp (MEDIF) reports a return to positive adjusted EBITDA, strong international growth, and a robust balance sheet, despite facing domestic revenue headwinds.
May 13, 2026
MediPharm Labs (OTC:MEDIF) reported first-quarter financial results on Wednesday. The transcript from the company's first-quarter earnings call has been provided below. This transcript is brought to y...
May 13, 2026
Q1 2026 Positive Adjusted EBITDA(1)Net Revenue of $9M with strong gross margins of 37%OPEX decreased 28% in Q1 2026 versus Q4 2025Company is virtually debt free, with a Q1 ending cash balance of $9.9 ...
May 13, 2026
MediPharm Labs (TSX:LABS) held its first-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-tim...
May 13, 2026
MediPharm Labs Corp (MEDIF) reports 8% annual revenue growth and improved profitability, driven by a robust international medical cannabis segment.
March 30, 2026